LGMD R1 Natural History Study
(GRASP-01-003 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.
Who Is on the Research Team?
Nicholas Johnson, MD
Principal Investigator
Virginia Commonwealth University
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessments including MR scans and baseline measurements
Observational Study
Participants undergo observational assessments including MR scans and various functional tests
Follow-up
Participants are monitored for safety and effectiveness after the observational period
What Are the Treatments Tested in This Trial?
Interventions
- Observational Study
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Commonwealth University
Lead Sponsor
University of Minnesota
Collaborator
Community Health Clinic
Collaborator
Amsterdam/Leiden University Medical Center
Collaborator
Newcastle University
Collaborator
University of Kansas Medical Center
Collaborator
Indiana CHC (Community Health Clinic)
Collaborator
University of California, Irvine
Collaborator
University of Kansas
Collaborator
University of Colorado, Denver
Collaborator